Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 1.76x is 11% below its 5-year average of 1.97x, near the high end of its 5-year range (-14.27x–3.29x).
219.07% above its 12-month average of 0.55x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -5.26x.
INTEREST COVERAGE RATIO
1.76x
INTEREST COVERAGE RATIO AVG TTM
0.55x
INTEREST COVERAGE RATIO AVG 3Y
1.89x
INTEREST COVERAGE RATIO AVG 5Y
1.97x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+219.07%
CURRENT VS 3Y AVG
-7.05%
CURRENT VS 5Y AVG
-10.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
+131.77%
vs the sector median at left
AdaptHealth Corp.
Market Cap
$795.58M
Interest Coverage Ratio
1.76x
TTM Avg
0.55x
3Y Avg
1.89x
5Y Avg
1.97x
Market Cap
$790.35M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$796.03M
Interest Coverage Ratio
N/A
TTM Avg
85.72x
3Y Avg
85.72x
5Y Avg
85.72x
Market Cap
$787.65M
Interest Coverage Ratio
-5.87x
TTM Avg
6.84x
3Y Avg
6.84x
5Y Avg
3.53x
Market Cap
$780.99M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$770.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$772.37M
Interest Coverage Ratio
1.73x
TTM Avg
1.55x
3Y Avg
1.27x
5Y Avg
1.31x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $795.58M | 1.76x | 0.55x | 1.89x | 1.97x |
| Geron Corporation (GERN)vs › | $790.35M | -1.65x | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $796.03M | N/A | 85.72x | 85.72x | 85.72x |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $787.65M | -5.87x | 6.84x | 6.84x | 3.53x |
| InMode Ltd. (INMD)vs › | $805.31M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $807.61M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $780.99M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $770.72M | N/A | N/A | N/A | N/A |
| Mesa Laboratories, Inc. (MLAB)vs › | $772.37M | 1.73x | 1.55x | 1.27x | 1.31x |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | -1.44x | N/A | N/A | N/A |
Interest Coverage
1.8x
Debt/Equity
1.50
Current Ratio
1.12
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -5.26x |
| 2026-04-10 | 0.27x |
| 2025-12-31 | 2.22x |
| 2025-09-30 | 2.64x |
| 2025-06-30 | 2.88x |
| 2025-03-31 | 0.82x |
| 2024-12-31 | 3.29x |
| 2024-09-30 | 2.02x |
| 2024-06-30 | 1.58x |
| 2024-03-31 | 1.56x |
| 2023-12-31 | -6.50x |
| 2023-09-30 | -14.27x |
| 2023-06-30 | 1.67x |
| 2023-03-31 | 0.82x |
| 2022-12-31 | 0.88x |
| 2022-09-30 | 1.86x |
| 2022-06-30 | 2.31x |
| 2022-03-31 | 2.08x |
| 2021-12-31 | 2.70x |
| 2021-09-30 | 3.12x |
| 2021-06-30 | 2.83x |
| 2021-03-31 | 0.69x |
| 2020-12-31 | 2.37x |
| 2020-09-30 | 1.07x |
| 2020-06-30 | 2.08x |
| 2020-03-31 | 1.04x |
| 2019-09-30 | -0.91x |
| 2019-06-30 | -1.25x |
